酵素補充療法（ERT）の世界市場レポート 2024年

酵素補充療法（ERT）市場規模は近年力強く成長しています。2023年の108億5,000万米ドルから2024年には117億2,000万米ドルへと、CAGR8.0％で拡大します。過去数年間の成長は、早期治療法の発見、先駆的な治療法の承認、疾患理解の拡大、臨床的成功例、規制当局の支援とインセンティブに起因しています。

酵素補充療法（ERT）市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR8.5％で162億1,000万米ドルに成長します。予測期間の成長は、医療への患者アクセスの増加、オーダーメイド治療と個別化医療、規制状況の変化、患者集団の意識の高まりに起因すると考えられます。予測期間の主な動向には、デジタルヘルス統合、患者中心のソリューションへの注力、新たなバイオマーカー調査、精密医療アプローチなどが含まれます。

酵素補充療法（ERT）市場の予測成長は、希少疾患、慢性疾患、遺伝性疾患の有病率の増加によって牽引されると予想されます。3カ月以上持続し、時間の経過とともに悪化する傾向がある慢性疾患は、特に高齢者人口の間で蔓延しつつあります。例えば、米国国立医学図書館の報告書によると、米国で少なくとも1つの慢性疾患を持つ50歳以上の人口は99.5％増加し、2020年の7,152万2,000人から2050年には1億4,266万人になると予測されています。このように、希少疾患、慢性疾患、遺伝性疾患の罹患率の増加は、酵素補充療法（ERT）市場の成長を促進する見通しです。

医療への支出の増加は、酵素補充療法（ERT）市場の成長に貢献すると予想されます。医療支出は、特定の医療システムや経済圏において、一定期間に医療サービス、商品、関連活動に費やされる金額の合計を意味します。ERTは専門的でコストがかかることが多いため、研究開発や臨床試験、検査に多額の費用が必要となります。例えば、英国国家統計局の報告によると、2020年から2021年にかけて、英国の医療支出は名目ベースで9.4％、実質ベースで9.7％増加しました。2021年の英国の医療支出総額は3,672億5,000万米ドル（約2,807億ポンド）で、医薬品支出は518億4,000万米ドル（約396億ポンド）に達し、予防医療への支出は459億3,000万米ドル（約351億ボンド）と倍増します。その結果、医療支出の増加が酵素補充療法（ERT）市場の成長を促進しています。

2023年の酵素補充療法（ERT）市場で最大の地域は北米でした。アジア太平洋は、予測期間中に酵素補充療法（ERT）世界市場レポートにおいて最も急成長する地域となる見込みです。酵素補充療法（ERT）市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の酵素補充療法（ERT）市場、酵素の種類別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• アガルシダーゼアルファ
• アガルシダーゼベータ
• ガルスルファーゼ
• その他
• 世界の酵素補充療法（ERT）市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 非経口
• 世界の酵素補充療法（ERT）市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ゴーシェ病
• ポンペ病
• ファブリー病
• その他
• 世界の酵素補充療法（ERT）市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 輸液センター
• その他

第7章 地域および国の分析

• 世界の酵素補充療法（ERT）市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の酵素補充療法（ERT）市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 酵素補充療法（ERT）市場の競合情勢
• 酵素補充療法（ERT）市場の企業プロファイル
  • Biomarin Pharmaceutical Inc.
  • Leadiant Biosciences Inc.
  • Pfizer Inc.
  • Sanofi SA
  • AbbVie Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Enzyme Replacement Therapy Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzyme replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzyme replacement therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The enzyme replacement therapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Enzyme Type: Agalsidase Alfa; Agalsidase Beta; Galsulfase; Other Enzyme Types
• 2) By Route Of Administration: Oral; Parenteral
• 3) By Application: Gaucher Disease; Pompe Disease; Fabry Disease; Other Applications
• 4) By End-Users: Hospitals; Infusion Centers; Other End-Users
• Companies Mentioned: BioMarin Pharmaceutical Inc.; Leadiant Biosciences Inc.; Pfizer Inc.; Sanofi S.A.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Enzyme replacement therapy (ERT) refers to a sort of medical treatment in which patients with chronic disorders brought on by insufficient or failing enzymes are given alternative enzymes. The body can complete the processes inhibited by the deficit by getting enzyme replacements. It is particularly effective at returning urinary GAG levels to normal and boosting liver and spleen development.

The main types of enzymes used in enzyme replacement therapy include agalsidase alfa, agalsidase beta, galsulfase, other enzyme types that are used in gaucher disease, pompe disease, fabry disease, others. Agalsidase alfa refers to a recombinant human alpha-galactosidase that is used in the treatment of fabry's disease as an enzyme replacement therapy. It has a long half-life and a broad therapeutic spectrum. Patients should be advised about the possibility of infusion-related symptoms and sensitivity. Agalsidase alfa is beneficial to enzyme replacement therapy because it aids in the treatment of Fabry disease. The enzyme replacement therapy is used by hospitals, infusion centers and others that is administered through oral and parenteral route.

The enzyme replacement therapy market research report is one of a series of new reports from The Business Research Company that provides enzyme replacement therapy market statistics, including enzyme replacement therapy industry global market size, regional shares, competitors with enzyme replacement therapy market share, detailed enzyme replacement therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the enzyme replacement therapy industry. This enzyme replacement therapy market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry

The enzyme replacement therapy market size has grown strongly in recent years. It will grow from $10.85 billion in 2023 to $11.72 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to growing early therapeutic discoveries, pioneering treatment approvals, expanded disease understanding, clinical success stories, regulatory support and incentives.

The enzyme replacement therapy market size is expected to see strong growth in the next few years. It will grow to $16.21 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing patient access to healthcare, tailored therapies and personalized medicine, regulatory landscape changes, growing patient population awareness. Major trends in the forecast period include digital health integration, focus on patient-centric solutions, emerging biomarker research, precision medicine approach.

The anticipated growth in the enzyme replacement therapy market is expected to be driven by the increasing prevalence of rare, chronic, and inherited disorders. Chronic diseases, which persist for three months or more and tend to worsen over time, are becoming more prevalent, especially among the elderly population. For example, a report from the US-based National Library of Medicine projected a 99.5% increase in the number of people aged 50 and older with at least one chronic condition in the USA, rising from 71.522 million in 2020 to 142.66 million by 2050. Thus, the growing incidence of rare, chronic, and inherited disorders is poised to fuel the growth of the enzyme replacement therapy market.

The increasing expenditure on healthcare is expected to contribute to the growth of the enzyme replacement therapy (ERT) market. Healthcare expenditure encompasses the total amount of money spent on healthcare services, goods, and related activities within a specific healthcare system or economy over a defined period. The specialized and often costly nature of enzyme replacement therapy (ERT) necessitates substantial spending on research and development, as well as clinical trials and testing. For instance, a report from the UK-based Office for National Statistics indicated that between 2020 and 2021, healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. The total healthcare expenditure in the UK in 2021 was $367.25 billion (£280.7 billion), with pharmaceutical expenditure reaching $51.84 billion (£39.6 billion) and spending on preventive care doubling to $45.93 billion (£35.1 billion) in 2021. As a result, the rise in healthcare expenditures is propelling the growth of the enzyme replacement therapy (ERT) market.

Product approvals have become a prominent trend gaining traction in the enzyme replacement therapy market. Various enzyme replacement therapy medications introduced by major players are securing approvals in the market. For example, in February 2023, Lamzede (velmanase alfa) received approval from the Food and Drug Administration, a US-based federal agency of the Department of Health. Lamzede is the first enzyme replacement therapy sanctioned in the United States for treating non-central neurological indications of alpha-mannosidosis, a rare genetic disorder characterized by the absence of the alpha-mannosidase enzyme. Administered as a 10mg injection once a week, Lamzede aids patients in regaining normal cellular function by mimicking the action of the alpha-mannosidase enzyme, thereby restoring healthy cellular functioning.

Major companies in the enzyme replacement therapy (ERT) market are strategically focusing on innovative treatment products and obtaining approvals for Pompe disease therapy to address the unmet medical needs of patients with late-onset Pompe disease. In response to the pressing medical needs for late-onset Pompe disease patients in the European Union, Amicus Therapeutics, a US-based biotechnology company, secured approval and launched a new Pompe disease therapy in June 2023. The treatment, comprising Pombiliti (cipaglucosidase alfa) and Opfolda (miglustat), serves as an enzyme replacement therapy for adults with late-onset Pompe disease, supported by clinical data and driven by potential market opportunities and regulatory backing.

In May 2021, Aceragen Inc., a US-based biopharmaceutical company, completed the acquisition of Enzyvant Therapeutics GmbH for an undisclosed amount. This strategic move is aimed at providing Aceragen access to a promising therapy for a devastating rare disease, leveraging Aceragen's expertise in the field, and reinforcing its position in the rare disease market. Enzyvant Therapeutics GmbH, a US-based company, specializes in developing and commercializing enzyme replacement therapy solutions for rare metabolic disorders.

Major companies operating in the enzyme replacement therapy market report are Biomarin Pharmaceutical Inc., Leadiant Biosciences Inc., Pfizer Inc., Sanofi S.A., AbbVie Inc., Genzyme Corporation, Johnson & Johnson Services Inc., Alexion Pharmaceuticals Inc., Shire plc, Recordati Rare Diseases Inc., Actelion Pharmaceuticals Ltd., Sangamo Therapeutics Inc., JCR Pharmaceuticals Co. Ltd., Horizon Pharma Public Limited Company, Protalix Biotherapeutics Ltd., Amicus Therapeutics Inc., AstraZeneca plc, Zoetis Inc., Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Merck & Co. Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Sangamo Therapeutics Inc., Retrophin Inc., Abeona Therapeutics Inc., Orchard Therapeutics plc, Ultragenyx Pharmaceutical Inc., Catalyst Biosciences

North America was the largest region in the enzyme replacement therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global enzyme replacement therapy market report during the forecast period. The regions covered in the enzyme replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the enzyme replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The enzyme replacement therapy market includes revenues earned by entities by providing Sebelipase alfa, Elosulfase alfa, Idursulfase, AL glucosidase alfa and Alpha1-Proteinase inhibitor enzyme replacement therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Enzyme Replacement Therapy Market Characteristics

3. Enzyme Replacement Therapy Market Trends And Strategies

4. Enzyme Replacement Therapy Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Enzyme Replacement Therapy Market Size and Growth

• 5.1. Global Enzyme Replacement Therapy Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Enzyme Replacement Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Enzyme Replacement Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Enzyme Replacement Therapy Market Segmentation

• 6.1. Global Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Agalsidase Alfa
• Agalsidase Beta
• Galsulfase
• Other Enzyme Types
• 6.2. Global Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• 6.3. Global Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Gaucher Disease
• Pompe Disease
• Fabry Disease
• Other Applications
• 6.4. Global Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Infusion Centers
• Other End-Users

7. Enzyme Replacement Therapy Market Regional And Country Analysis

• 7.1. Global Enzyme Replacement Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Enzyme Replacement Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Enzyme Replacement Therapy Market

• 8.1. Asia-Pacific Enzyme Replacement Therapy Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Enzyme Replacement Therapy Market

• 9.1. China Enzyme Replacement Therapy Market Overview
• 9.2. China Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Enzyme Replacement Therapy Market

• 10.1. India Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Enzyme Replacement Therapy Market

• 11.1. Japan Enzyme Replacement Therapy Market Overview
• 11.2. Japan Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Enzyme Replacement Therapy Market

• 12.1. Australia Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Enzyme Replacement Therapy Market

• 13.1. Indonesia Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Enzyme Replacement Therapy Market

• 14.1. South Korea Enzyme Replacement Therapy Market Overview
• 14.2. South Korea Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Enzyme Replacement Therapy Market

• 15.1. Western Europe Enzyme Replacement Therapy Market Overview
• 15.2. Western Europe Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Enzyme Replacement Therapy Market

• 16.1. UK Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Enzyme Replacement Therapy Market

• 17.1. Germany Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Enzyme Replacement Therapy Market

• 18.1. France Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Enzyme Replacement Therapy Market

• 19.1. Italy Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Enzyme Replacement Therapy Market

• 20.1. Spain Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Enzyme Replacement Therapy Market

• 21.1. Eastern Europe Enzyme Replacement Therapy Market Overview
• 21.2. Eastern Europe Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Enzyme Replacement Therapy Market

• 22.1. Russia Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Enzyme Replacement Therapy Market

• 23.1. North America Enzyme Replacement Therapy Market Overview
• 23.2. North America Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Enzyme Replacement Therapy Market

• 24.1. USA Enzyme Replacement Therapy Market Overview
• 24.2. USA Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Enzyme Replacement Therapy Market

• 25.1. Canada Enzyme Replacement Therapy Market Overview
• 25.2. Canada Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Enzyme Replacement Therapy Market

• 26.1. South America Enzyme Replacement Therapy Market Overview
• 26.2. South America Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Enzyme Replacement Therapy Market

• 27.1. Brazil Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Enzyme Replacement Therapy Market

• 28.1. Middle East Enzyme Replacement Therapy Market Overview
• 28.2. Middle East Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Enzyme Replacement Therapy Market

• 29.1. Africa Enzyme Replacement Therapy Market Overview
• 29.2. Africa Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Enzyme Replacement Therapy Market Competitive Landscape And Company Profiles

• 30.1. Enzyme Replacement Therapy Market Competitive Landscape
• 30.2. Enzyme Replacement Therapy Market Company Profiles
  • 30.2.1. Biomarin Pharmaceutical Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Leadiant Biosciences Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Pfizer Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sanofi S.A.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. AbbVie Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Enzyme Replacement Therapy Market Competitive Benchmarking

32. Global Enzyme Replacement Therapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Enzyme Replacement Therapy Market

34. Enzyme Replacement Therapy Market Future Outlook and Potential Analysis

• 34.1 Enzyme Replacement Therapy Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Enzyme Replacement Therapy Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Enzyme Replacement Therapy Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer